Alim stock alert: halper sadeh llc is investigating whether the sale of alimera sciences, inc. is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of alimera sciences, inc. (nasdaq: alim) to ani pharmaceuticals, inc. for $5.50 per share in cash at closing and one non-tradable contingent value right representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027 is fair to alimera shareholders. halper sadeh encourages alimera shareholders to click here to learn more about t.
ALIM Ratings Summary
ALIM Quant Ranking